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Abstract:  
(1) Preclinical studies have shown that exposure to inhalational anesthetics 
in developing brain causes neuronal cell death and cognitive impairment. On 
the other hand, some studies reported neuroprotective effects of anesthetics. 
In this study, we investigated a common mechanism that causes 
neurotoxicity and neuroprotection based on our previous study that 
inhalational anesthetics caused endoplasmic reticulum (ER) stress. (2) 
Neuroblastoma cells were exposed to sevoflurane, then cultured under 1% 
oxygen. The effect of pre-exposure of sevoflurane was evaluated by the 
expression of proteins related to the unfolded protein response (UPR). Adult 
Binding immunoglobulin protein mutant mice and wild-type mice were 
exposed to sevoflurane, and their cognitive function was evaluated by radial 
maze tests. The results were compared to those of mice with fetal exposure 
in the previous study. (3) Sevoflurane pre-exposure reduced the expression 
of CHOP, a cell death related transcriptional factor in neuroblastoma cells. 
In adult wild-type mice, not the mutant, pre-exposure to anesthetics 
significantly improved cognitive function, while mice with fetal exposure 
showed cognitive impairment. (4) Inhalational anesthetic exposure causes 
ER stress, leading to adaptive response, the UPR. The UPR may enhance the 
capacity of cells against injuries and improve neuronal functions in adult 
mice, not in developing mice. 
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1. Introduction 
General anesthesia is an essential medical treatment for surgery. 
Inhalational anesthetics provide adequate loss of consciousness and a certain 
degree of analgesia. They are widely used in current medicine. The premise 
of general anesthesia is reversible. It has been accepted that the inhalational 
anesthetic loses its effect if it is stopped and excreted from the site of effect. 
The whole body returns to its original state including the nervous system. 
However, in recent years it has become clear that the action of inhalational 
anesthetics is not necessarily reversible. Jevtovic-Todorovic showed that 
pediatric anesthesia in 7-d-old infant rats using midazolam, nitrous oxide, 
and isoflurane caused widespread apoptotic neurodegeneration in the 
developing brain and persistent cognitive impairments [1]. Subsequent 
studies confirmed that common inhalational anesthetics like isoflurane and 
sevoflurane causes neuronal degeneration in developing brain [2]. They 
impaired neurogenesis, thus induced delayed-onset neurocognitive 
dysfunction in infant rats [3]. The effect of repeated exposures to sevoflurane 
in infant was also evaluated in rhesus monkeys. Early sevoflurane exposures 
within one month after birth caused increased anxiety-related emotional 
behaviors at 6 months age [4] and late-onset of impaired visual recognition 
memory after 12 months age [5]. 
Retrospective human clinical cohort studies revealed that multiple 
exposure of anesthesia before age 2 [6] or 4 year [7] was a significant risk 
factor of later learning disabilities. On the other hand, the sibling-matched 
cohort study (the Pediatric Anesthesia Neurodevelopment Assessment, 
PANDA study) showed that single anesthetic exposure to otherwise healthy 
children subjected to inguinal hernia surgery before age 36 months did not 
cause cognitive dysfunction in later childhood [8]. The General Anesthesia 
compared to Spinal anesthesia (GAS) trial also revealed that sevoflurane 
anesthesia just less than 1 hour in infancy did not increase the risk of adverse 
neurodevelopmental outcome at 2 years of age compared with awake-
regional anesthesia [9]. Healthy infants seem to withstand against single 
exposure to anesthetics for short duration.  
Preclinical studies confirm neurotoxicity of inhalational anesthetics in 
developing neurons [2], while several laboratory studies showed 
neuroprotective activity of inhalational anesthetics. Isoflurane decreased 
neuronal progenitor proliferation in rats at postnatal day 7, however, it 
increased the proliferation at postnatal day 60 [3]. Sevoflurane was shown to 
reduce focal ischemic brain damage in a rat experimental model [10]. 
Neuroprotective effects of inhalational anesthetics such as sevoflurane and 
isoflurane were suggested to be medicated by reducing N-methyl-D-
aspartate (NMDA) excitotoxicity [11,12]. Sevoflurane exposure was also 
shown to improve cognitive function in young (8-10 weeks) and aged rats 
(19 months) [13]. The general mechanism underlying the conflicting effects, 
neurotoxicity and neuroprotection of inhalational anesthetics is uncertain.    
One possible factor causing the neurotoxicity of inhalational anesthetics 
is the change in intracellular Ca2+ kinetics [14]. The endoplasmic reticulum 
(ER) is the main Ca2+ pool of cells, and Ca2+ is released from the ER into the 
cytosol via the inositol 1,4,5-triphosphate receptor (ITPR) and ryanodine 
receptor on the ER membrane [15-17]. Extracellular Ca2+ enters the 
cytoplasm from voltage-dependent calcium channels and excitatory amino 
acid receptors such as NMDA receptor on the plasma membrane [15]. 
Inhalational anesthetics affect those Ca2+ channel receptors and induce 
aberrant rise in cytoplasmic Ca2+ [18]. Excess cytoplasmic Ca2+ enters the 
mitochondria and induces the release of cytochrome C, resulting in the 
activation of caspases and cell death [19,20]. Since ER molecular chaperones 
are Ca2+ binding proteins, aberrant Ca2+ mobilization disturbs protein folding 
in the ER and causes ER stress [21]. 
Secreted proteins and membrane proteins are synthesized by ribosomes 
on the ER membrane. They are inserted into the ER and folded for functional 
proteins with mature structures by the interaction with ER molecular 
chaperones like binding immunoglobulin protein (BiP). Then, they are 
transported to the secretory pathway to function such as cell surface 
receptors or secretory proteins [21,22]. ER stresses such as hypoxia, 
ischemia, malnutrition or mutated proteins initiates an adaptive response 
called unfolded protein response (UPR) [23]. UPR enlarges the capacity of 
cells against ER stress by the increase in the production of ER molecular 
chaperones, the degradation of unfolded proteins and the repression of newly 
protein synthesis [24]. However, protective effects of the UPR is limited. 
Massive ER stress beyond the adaptive capacity caused cellular dysfunction 
and cell death, leading to human disorders such as cardiovascular disease 
[25] and neurodegenerative diseases [26-28]. 
We previously showed that the exposure to inhalational anesthetics 
induced ER stress, leading to neuronal cell death and cognitive dysfunction 
in developing brain using a knock-in mouse expressing a mutant Bip gene 
[29,30]. The BiP protein is a major ER-resident molecular chaperone 
assisting in the protein folding and the regulation of the UPR [31]. ER 
membrane proteins such as protein kinase RNA (PKR)-like ER kinase 
(PERK, or eukaryotic translation initiation factor 2 alpha kinase 3; 
EIF2AK3), endoplasmic reticulum to nucleus signaling 1 (ERN1, or IRE1), 
and activating transcription factor 6 (ATF6) are bound to BiP in the resting 
state [23] . Under ER stress, BiP binds to unfolded proteins and these 
membrane proteins are activated. ERN1, and EIF2AK3 are multiplexed and 
activated by autophosphorylation [32]. ATF6 is transported to the Golgi 
complex, cleaved, and the carboxyl terminus acts as a transcription factor, 
facilitating transcription of molecular chaperones such as BiP and 
transcriptional factors such as XBP1 and C/EBP homologous protein 
(CHOP) [33]. 
Wild-type BiP is secreted from the ER to the Golgi at a constant rate, 
while the carboxyl-terminal Lys-Asp-Glu-Leu (KDEL) sequence of BiP is 
recognized by the KDEL receptor in the Golgi [34]. BiP is retrieved to the 
ER by coat protein I (COPI) vesicles [35]. Mutant BiP lacks the KDEL 
sequence and has impaired for ER functions [22]. The homozygous mutant 
Bip mice are lethal on the first day after birth due to impaired synthesis of 
pulmonary surfactant [36]. The heterozygous Bip mutant mice is viable and 
developed late-onset neurodegenerative diseases [30,37].   
In this study, we examined the relationship between the UPR and the 
neurotoxicity and neuroprotection of inhalational anesthetics using the Bip 
mutant mice and cultured neuronal cells. 
 
2. Results 
2.1. Exposure to inhalational anesthetics induces the UPR 
In order to assess whether inhalational anesthetics affect ER functions at 
cellular level, we exposed mouse neuroblastoma, neuro2a cells to 
sevoflurane. Neuro2a cells were cultured under conditions of 37 ° C, 40% 
O2 and 5% CO2. Neuro2a cells were exposed to 3% sevoflurane for 2.5 
hours, 5 hours or 7.5 hours. The cells were collected and analyzed for protein 
expression related to the UPR by Western blotting (Figure 1). Under ER 
stress ATF6 is translocated from the ER to the Golgi complex and cleaved. 
The carboxyl terminus acts as a transcription factor, facilitating the 
transcription of genes related the UPR such as BiP and other transcriptional 
factors like XBP1 and CHOP [33]. BiP is essential for regulating protein 
folding and the UPR in the ER and acts cytoprotectively [31]. CHOP is a 
transcription factor that expresses by ER stress and induces cell death [38,39]. 
BiP is constitutively expressed and promotes the folding of nascent proteins 
in the ER. Sevoflurane exposure caused the enhanced expression of cleaved 
ATF6 , indicating that the UPR was initiated. The expression of XBP1 and 
BiP was observed even under the control condition, while their expression 
levels were increased more with longer exposure to sevoflurane. Although 
CHOP was hardly expressed under the control condition, cells exposed to 
sevoflurane for longer hours expressed more. The significant expression of 
CHOP was observed at 7.5 hours. These results suggested that sevoflurane 
affected cells and inhibited the protein folding of nascent proteins in the ER, 
inducing the UPR. The UPR enhanced the expression of cytoprotective ER 
chaperones like BiP, but also induced the expression of CHOP that caused 
cell death with much ER stress. 
  
Figure 1. Sevoflurane exposure initiated the UPR. Culture cells, 
neuro2a cells, were exposed to 3% sevoflurane for 2.5, 5, or 7.5 hours. 
The cells were collected and analyzed by Western blotting.  
Sevoflurane exposure activated ATF6 and induced the expression of 
XBP-1, a transcriptional factor that enhanced the expression BiP, a major 
ER chaperone. CHOP, a transcription factor causing apoptotic cell death 
during ER stress,was also induced especially at 7.5 hours.  
2.2. Anesthetc exposure caused cognitive impairment in the developing 
brain. 
Then, we assessed the effects of inhalational anesthetics on developing 
brain in vivo. Because an exposure of neonatal mice to inhalational 
anesthetics could suppress their respiration and circulation, possibly 
resulting in hypoxia and low blood flow, we exposed pregnant mice two days 
before delivery to sevoflurane. Female wild-type mice were mated with male 
heterozygous mutant Bip mice . Pregnant mice on day 17.5 of gestation were 
exposed to 3% sevoflurane for 3 hours under 40% O2. Body temperature, tail 
blood pressure, tail blood flow and percutaneous oxygen saturation in some 
mice were measured during exposure. Overall, blood pressure decreased to 
some extent, but blood flow and SpO2 did not decrease. The newborns were 
1: 1 with wild-type and heterozygous mutant Bip mice, were continued to be 
raised under the parent mice. At 10 weeks of age, the cognitive function test 
was performed. Radial maze testing is widely used as a mouse spatial 
cognitive function test [40]. The testing was performed for 5 consecutive 
days, during which learning effects (shorter completion time and higher 
correct rate) were observed in individual mice. Radial maze testing at 10 
weeks revealed that both wild-type mice and the heterozygous mutant Bip 
mice with fetal anesthetic exposure had significantly longer completion time 
(P <0.01) and had a lower correct answer rate (P <0.05) compared to 
unexposed mice (Figure 2, Supplementary Materials 1). 
 Figure 2. Anesthetic exposure at perinatal period had negative effects 
on spatial working memory in young mice. Eight-arm radial maze 
testing was performed in adult wild-type mice (+/+; circle) and Bip 
mutant mice (Bm; triangle) at 10 weeks after sevoflurane exposure (+/+ 
sevo, n = 12, closed red circle; Bm/+ sevo, n = 16, closed red triangle) 
and without exposure (+/+, n = 6, open blue circle; Bm/+, n = 8; open 
blue triangle). Tests were performed over 5 days after the exposure. 
Significance was determined by one-way repeated measures ANOVA 
followed by Bonferroni’s multiple comparison testing. (a) Correct 
answer rates are shown as the average value of each group + SEM. The 
ratio of successful attempts to overall attempts was the correct answer 
rate (0.0–1.0). (b) Completion times are the average of each group + 
SEM. (Data extracted from DATASET S1 and DATASET S2, Front. 
Neurosci. 12:753. doi:10.3389/fnins. 2018.00753). Fetal anesthetic 
exposure caused lower correct answer rate (P < 0.05) (a) and longer 
completion time (P < 0.01) (b) compared to unexposed mice in both Bip 
mutant mice and wild-type mice. 
2.3 Moderate exposure to anesthetics causes cytoprotective effects 
through the UPR. 
Inhalational anesthetic exposure was thought to cause ER stress at the 
cellular level, which induced the expression of CHOP in Figure 1. The 
UPR also induces molecular chaperones such as BiP that are 
cytoprotective. Then, we exposed neuro2a cells to 3% sevoflurane for 5 
hours, returned them to the normal culture conditions of 37 °C, 40% O2 and 
5% CO2 for 12 hours, allowing them to compensate the stress. After that, 
cells were cultured for 17 hours under hypoxia of 1% O2. The expression of 
BiP and CHOP was evaluated by Western blotting. When cells were 
exposed to hypoxia alone, the expression of CHOP was induced to some 
extent, whereas in cells previously exposed to sevoflurane, the expression 
of CHOP was suppressed, suggesting the neuroprotection. When the 
expression of BiP was suppressed by siRNA, the expression of CHOP 
became prominent. The effect of sevoflurane for neuroprotection seemed to 
disappear. These results suggested that pre-exposure to sevoflurane induced 
the UPR that increased the capacity of cells to tolerate against hypoxic 
invasion by the expression of cytoprotective chaperones like BiP (Figure 3, 
Supplementary Materials 2) 
 Figure 3. Sevoflurane pre-exposure may induce the UPR and reduce 
the damage caused by hypoxia. 
(a) Cells were exposed to 3% sevoflurane for 5 hours. After 12 hour’s 
recovery time, cells were exposed to 1% O2 hypoxia for 17 hours 
before collection. Hypoxia alone induce the expression of CHOP. 
Sevoflurane pre-exposure reduced the expression of CHOP. siBiP 
enhanced the expression of CHOP. (b) Densitometry was performed 
based on three experiments. Relative density of CHOP to that of 
tubulin was measured by Image J and analyzed by one-way analysis 
of variance (ANOVA) followed by Dunnett’s multiple comparison 
test. Values indicate mean + SEM. Control vs siBiP; P < 0.05.  
2.4 Sevoflurane pre-exposure improves cognitive function in adult wild 
type mice, not in the Bip mutant mice. 
The effect of inhalational anesthetics on cognitive function was 
evaluated in adult mice. One-year old wild-type and heterozygous Bip 
mutant mice were exposed to 3% sevoflurane for 3 hours under 40% O2. A 
radial maze test was performed for 5 days from the 7th day after the exposure. 
There was no significant difference in cognitive function between unexposed 
wild-type and mutant Bip mice, whereas the wild-type mice exposed to 
sevoflurane had significantly higher correct answer rates compared to 
unexposed Bip mutant mice (P <0.05). In addition, the wild-type mice 
exposed to sevoflurane significantly shortened the completion time 
compared to the unexposed wild-type mice (P <0.05). Pre-exposure of 
inhalational anesthetics significantly improved cognitive function in the 
wild-type mice, while no such effect was seen in the Bip mutant mice (Figure 
4, Supplementary Materials 3).  
These results suggest that the exposure to inhalational anesthetics may 
have neurotoxicity, which induces adaptive responses like the UPR. The 
UPR enhances the capacity of cells and individuals to tolerate against the 
following insults. This can be applied to healthy wild-type individuals, not 
sensitive individuals such as neonates with developing neuronal cells and 
aged individuals with degenerative neuronal cells (Figure 2, 4). 
 Figure 4. Anesthetic exposure had positive effects on spatial working 
memory in adult wild-type mice, not in mutant BiP mice. Eight-arm 
radial maze testing was performed in adult wild-type mice (+/+; circle) 
and mutant-Bip mice (Bm; triangle) at 7 days after sevoflurane (sevo) 
exposure (+/+ sevo, n = 4, closed red circle; Bm/+ sevo, n =  5, 
closed red triangle) and without exposure (+/+, n = 7, open circle; Bm/+, 
n = 10; open triangle). Tests were performed over 5 days. Significance 
was determined by one-way repeated measures ANOVA followed by 
Bonferroni’s multiple comparison testing. (a) Correct answer rates are 
shown as the average value of each group + SEM. The ratio of successful 
attempts to overall attempts was the correct answer rate (0.0–1.0). (b) 
Completion times are the average of each group + SEM.  
3. Discussion 
The exposure to inhalational anesthetics is neurotoxic depending on the 
duration and dose. Moderate exposure to an appropriate subject could be 
beneficial. The exposure to inhalational anesthetics seems to function as a 
preconditioning. The concept of preconditioning has been around for a long 
time [41]. In cardiac surgery, it has been known that a moderate ischemia is 
added in advance as an ischemic preconditioning, whereby the resistance to 
a later longer ischemia becomes stronger [42]. It has been shown that 
ischemic preconditioning is effective not only in heart [43] but also in 
nervous system [44], skeletal muscle [45], liver [46] and the like. The 
background of beneficial effects includes the changes in various gene 
expression due to moderate preconditioning. The production of heat-shock 
proteins [47] and ER molecular chaperone, BiP [48] has also been reported. 
Injuries that disturb protein folding in cells induce heat shock response in the 
cytoplasm and the UPR in the ER, increasing the production of 
cytoprotective molecular chaperones such as heat shock protein 70 (HSP70) 
and BiP, respectively. Thereby, cells become resistant to further cytotoxic 
injuries. Such integrated stress response is involved in various pathological 
conditions [49,50]. In anesthesia for cardiac surgery, it has been shown that 
inhalational anesthetics have the similar effect as ischemia [51]. Thus, 
sevoflurane has been used as a clinically beneficial agent as anesthetic 
preconditioning or pharmacological preconditioning [52]. Inhalational 
anesthetics act on cells throughout the whole body, and the phenomenon seen 
in the myocardium is thought to occur in all tissues including the nervous 
system. In fact, there are several studies that revealed neuroprotective effects 
of anesthetic preconditioning [53-56].  
We have shown that sevoflurane exposure induces the UPR in this study 
and in the previous study [29]. The UPR can enhance the resistance of cells 
to injuries. However, sevoflurane itself acts as an ER stress and eventually 
induces cell death if the exposure is too much. Developing brain is highly 
sensitive to injuries, and even certain types of cells among the same 
individual, such as stem cells which are actively dividing, are thought to be 
highly sensitive. If some of important neuronal cells suffer from migration 
failure or cell death, the effect may later appear as cognitive dysfunction or 
higher brain damage, although it is not immediately apparent. Disturbance 
of neuronal migration has been reported as an adverse effect of inhalational 
anesthetics on developing brain in a rat study [57]. Fetal isoflurane exposure 
diminished the expression of reelin there. Reelin is a large glycoprotein 
secreted by neurosecretory Cajal-Retzius cells and mediates cortical 
neuronal migration in developing brain [58]. Dysfunction of reelin has been 
suggested to cause higher brain disorders such as autism [59]. Interestingly, 
the homozygous Bip mutant mice revealed impaired neuronal migration [60]. 
The production of reelin in their Cajal-Retzius cells is diminished, while the 
transcription of reelin gene is preserved. Dysfunction of BiP may affect the 
folding of large secretory proteins like reelin in the Bip mutant neonates. 
Protein folding environment in the ER is highly sensitive to injuries such as 
ischemia, hypoxia, toxic substances and malnutrition. Thus, the UPR may be 
one of the most important cellular adaptive mechanisms to injuries. 
Following our initial report that fetal exposure to inhalational anesthetics 
caused ER stress and neuronal cell death [29], several studies have confirmed 
that general anesthesia causes ER stress [61-67]. 
In our previous study, the fetal exposure of 3% sevoflurane for 3 hours 
in the homozygous Bip mutant mice caused neuronal cell death, not in the 
heterozygous mutant and the wild-type mice [29]. After delivery, both the 
heterozygous mutant and wild-type mice with fetal exposure appeared 
normal. However, it turned out that they suffered cognitive dysfunction at 10 
weeks after birth. On the other hand, the same exposure of 3% sevoflurane 
for 3 hours slightly improved the cognitive function at 7 days after the 
exposure in adult wild-type mice, not in the heterozygous Bip mutant. 
Overall outcomes from anesthetic exposure seem to depend on the balance 
between the amount of injuries and the sensitivity of subjects. In the 
heterozygous Bip mutant mice, cognitive function tends to decline faster than 
wild-type mice. However, at the old age, cognitive function of wild-type 
mice also fades, so there is no significant difference between wild-type and 
the mutant [30]. Cognitive function is superior in young mice, and aging 
affects more than genotype. In sevoflurane fetal exposure, cognitive function 
declines regardless of genotype. In the adult exposure, wild-type mice 
showed slightly improved cognitive function. No such changes in cognitive 
function were observed in the Bip mutant mice (Figure 4). 
There is no clear evidence from animal experiments or clinical studies 
that sevoflurane anesthesia worsens postoperative cognitive function. One 
study showed that one minimum alveolar concentration (MAC) sevoflurane 
exposure improved cognitive function in 10 weeks-old rats and 20 months-
old rats [13]. In another study using APP23 Alzheimer's disease model 
transgenic mice expressing mutant amyloid-β precursor protein and wild-
type control mice, exposure to one MAC isoflurane for 2 hours improved 
cognitive function in both types of mice. Regardless of genotype, young 
mice (4 months-old) were superior in cognitive function compared to aged 
mice (14 to 16 months-old) [68]. 
Several clinical studies also suggested a beneficial effect of inhalational 
anesthetics in post-operative cognitive function, however other studies 
suggested an increased risk for post-operative cognitive decline. In a 
randomized controlled trial for patients with on-pump cardiac surgery, 
compared to propofol anesthesia, sevoflurane anesthesia showed better 
results in the cognitive function test on the 2nd to 6th postoperative days [69]. 
There is another report that propofol anesthesia had less cognitive 
impairment one week after surgery than sevoflurane anesthesia when 
patients over 65 years of age undergo cancer surgery for more than 2 hours 
[70]. In a postoperative cognitive function study on twin surgical patients, 
the effect of surgical anesthesia was slight. Their cognitive function was 
decreased slightly in major surgery, and slightly improved in hip and knee 
surgery [71]. In a retrospective cohort study for 70-89 years-old people, 
whether or not they experienced general anesthesia after 40 or 60 years-old 
was not related to their cognitive function [72]. In a prospective cohort study 
of people over 65 years of age with no dementia, there was no relationship 
between anesthesia experience and the incidence of dementia or Alzheimer's 
disease. Patients who underwent less invasive surgery had a lower incidence 
of dementia [73]. In a study comparing newly diagnosed patients as dementia 
over 50 years of age with control group, people with general anesthesia had 
a higher incidence of dementia. In addition, people with a history of diabetes, 
hypertension, or cerebral infarction had a higher incidence of dementia [74]. 
Inhalational anesthetics have longer exposure times, and the higher the 
exposure concentration, the greater the invasion. It is difficult to determine 
how much invasiveness is appropriate as preconditioning. Sensitivity varies 
from individual to individual, and it seems that the sensitivity varies 
depending on each cell type even within the same individual. The degree of 
invasion that is appropriate as preconditioning varies from patients to 
patients and may also depend on the patient's condition at the time of 
exposure. 
 
4. Materials and Methods  
4.1 Cells and reagents 
Murine neuroblastoma cell line, neuro2a, were cultured with a complete 
medium that consisted of Dulbecco’s modified Eagle’s medium (DMEM; 
Sigma Chemical Co.) with 10 % fetal bovine serum, 2 mM glutamine, 50 
µg/ml streptomycin and 50 U/ml penicillin G at 37°C in a 5% CO2 incubator. 
In hypoxic experiments, N2 is injected into the incubator to 1% oxygen 
concentration. The following antibodies were used: mouse mAb against γ-
tubulin (Sigma Chemical), mouse mAb SPA-827 against BiP (KDEL 
sequence) (Stressgen, Victoria), rabbit antiserum against CHOP/GADD153 
(Santa Cruz Biotechnology), mouse mAb 37-1, 73-505 against ATF6α (Bio 
Academia) and mouse mAb M-186, sc-7160 against XBP-1 (Santa Cruz 
Biotechnology). siRNA oligonucleotides for BiP (sc-35522) and control (sc-
37007) were purchased from Santa Cruz Biotechnology. For siRNA uptake, 
neuro2a cells were transfected with siRNA oligonucleotide according to 
manufacturer’s instructions. At 24 hours post-transfection, the medium was 
changed to a complete medium and cells were exposed to sevoflurane. 
4.2 Animals 
This study was carried out in accordance with the recommendations of 
the guidelines for animal experiments of Chiba University. The protocol (30-
132) was approved by the Institutional Animal Care Committee of Chiba 
University, Chiba, Japan. Generation of the knock-in mouse expressing a 
mutant BiP lacking the carboxyl-terminal KDEL sequence was described 
previously [36]. The missing KDEL sequence was replaced with a 
hemagglutinin (HA) tag. The heterozygous Bip mutant male mice (Bm/+) 
were mated with wild-type (C57BL/6, +/+) female mice, and offspring 
(wild-type and heterozygous mutant) were bred for use in experiments.  
4.3 Inhalational anesthetic exposure 
Adult heterozygous Bip mutant mice and wild-type mice (about one-year 
old) were exposed to 3% sevoflurane for 3 hours as previously described 
[29]. Neuro2a cells were exposed to 3% sevoflurane for 2.5-7.5 hours as 
previously described [29]. Previous studies suggested that 3.0% sevoflurane 
was almost equivalent to 0.6 MAC for mice [75]. 
4.4 Eight-arm radial maze test 
Mice were subjected to eight-arm radial maze test 7 days after 
sevoflurane exposure as previously described [30]. The total time for the 
mouse to eat all the food in the eight arms was the completion time (seconds). 
Attempts to enter arms without bait were counted as errors, while attempts 
to enter arms with food were counted as successes. The ratio of successful 
attempts to overall attempts was the correct answer rate (0.0–1.0). Testing 
was carried out daily for 5 days (Appendix B, Figure 4). The data of mice 
with fetal sevoflurane exposure was extracted from DATASET S1 and 
DATASET S2, Front. Neurosci. 12:753. doi: 10.3389/fnins.2018.00753 in 
our previous study (Supplementary Materials 1, Figure 2). 
4.5 Western blotting  
Cultured cells were homogenized in a buffer containing 0.4% (w/v) 
Nonidet P-40, 0.2% N-lauroylsarcosine, 10mM Tris/HCl pH 8.0, 30mM 
EDTA, 10µg/ml aprotinin, 10µg/ml leupeptin, 30 µg/ml N-acetyl-L-leucinal-
L-lecinal-L-norleucinal (ALLN, Sigma Chemical). Western blotting was 
performed and analyzed with LAS-1000 and Image Gauge Software (Fuji 
Photo Film Co. Ltd., Tokyo, Japan) as previously described [29]. 
Densitometry was performed using ImageJ software (Wayne Rasband, NIH, 
Bethesda, MD). 
4.6 Statistical analysis  
Results of radial maze test are shown as means + standard error of the 
mean (SEM). Repeated measures analyses of variance (ANOVAs), followed 
by Bonferroni multiple comparison tests, were performed to compare values 
between groups (GraphPad Prism 4.0, GraphPad Software, San Diego, CA). 
Statistical significance was accepted at P < 0.05. Densitometry of the images 
for CHOP was analyzed by one-way ANOVA, followed by Dunnett’s 
multiple comparison test. 
 
5. Conclusions 
Inhalational anesthetics cause neurotoxicity, while they can also induce 
adaptive responses such as the UPR in neuronal cells. Therefore, inhaled 
anesthetics may be neuroprotective. It is necessary to use inhalation 
anesthetics appropriately depending on the patient's condition. 
  
Supplementary Materials: Supplementary materials can be found at 
www.mdpi.com/xxx/s1. 
Supplementary Materials 1 (SM1) is the data for radial maze test of 10 
weeks-old mice in Figure 2. 
Supplementary Materials 2 (SM2) is the data for densitometry in Figure 3 
(b). 
Supplementary Materials 3 (SM3) is the data for radial maze test of 1-year-
old adult mice in Figure 4. 
Author Contributions: conceptualization, T.A.; formal analysis, H.K., H.J., 
M.K. and T.A.; investigation, H.K., H.J. M.K and T.A.; data curation, T.A. ; 
writing—original draft preparation, T.A.; writing—review and editing, T.A., 
H.K., H.J; project administration, T.A.; funding acquisition, M.K., H.K. and 
T.A. 
Funding: This work was funded by Grants-in-Aid for Japan Society for the 
Promotion of Science (KAKENHI) to H.K. (18K16473), M.K. (15K20031) 
and T.A. (17K11114). 
Conflicts of Interest: The authors declare no conflict of interest. The 
funders had no role in the design of the study; in the collection, analyses, or 
interpretation of data; in the writing of the manuscript, or in the decision to 
publish the results. 
Abbreviations 
ER  
UPR 
BiP 
KDEL 
COPI 
CHOP 
ERN1 
PERK 
ATF6  
XBP1  
NMDA 
ITPR  
MAC 
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